we're developing smarter medicine

Intelligent Molecular Therapeutics (IMT) is the process of developing intelligent molecules in order to solve health problems biologically -- not chemically. IMT harnesses the therapeutic capabilities of specific molecules, enabling us to acutely evaluate the state of a cell in order to determine the level of action required based on a set of triggers. Only if those triggers are found will the technology deliver the therapeutic solution.


Biiosmart is a pioneer in the creation of intelligent molecular therapeutics. We specialize in the reluctant pursuit of exploring molecular curiosity.

r&d process


We explore our platform technology from within to identify various areas of application. Our people constantly screen the interaction between the developed molecules and their target subject until a promising candidate is discovered.

Preclinical evaluation

Each candidate is refined comprehensively through stability, safety, efficacy, and biocompatibility testing before being approved for human trials. Once the point of intelligence has been confirmed, production testing can be formulated for clinical use.

Clinical advancement

A clinical trial is conducted with human volunteers who test the intelligence of the candidate, whether prevention or treatment. Our partners in research are fundamental in the advancement of innovative therapies.

Ongoing development

When a candidate has completed successful clinical trials, it is then submitted for review by local regulatory agencies. Ongoing investigation is continued to review findings and explore new developments.

our r&d focuses on the world's current and future epidemics

Infectious Disease


Sexually Transmitted Infections

Wound care


Gastroenterology Infections

product pipeline

  • Herpes simplex virus
  • Human papillomavirus
  • Chronic and non-healing wounds
  • Antibiotic resistant strains of bacteria and viruses
  • Influenza
  • Bacterial Pneumonia
  • Viral Pneumonia
  • Gastroenteritis
  • Human Papillomavirus (warts)
  • C. Difficile infection
  • Parainfluenza
  • Hepatitis B
  • Hepatitis C
  • HIV
  • Bronchiolitis
  • Ebola infection